CATHEPSIN-HEMMER

European patent · EP3720840 · In force

Register entry

Publication number
EP3720840
Application number
EP18839759
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 5, 2018
Published
Oct 14, 2020
Granted
Jan 19, 2022
Protection ends at the latest
Dec 4, 2038
Next annual fee due
Dec 31, 2026
IPC classes
C07C 317/14 (2006.01)
A61K 31/165 (2006.01)
A61P 19/10 (2006.01)
Priority
NL 2020021 05.12.2017
NL 2021544 03.09.2018
PCT application
PCT/NL2018/050810 05.12.2018
PCT publication
WO2019/112426 13.06.2019
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 6, 2026

    Change

    Published in Swissreg on 06.01.2026

  2. Jan 17, 2025

    Change

    Published in Swissreg on 17.01.2025

  3. Jan 16, 2024

    Change

    Published in Swissreg on 16.01.2024

  4. Jan 4, 2023

    Change

    Published in Swissreg on 04.01.2023

  5. Nov 30, 2022

    Change

    Published in Swissreg on 30.11.2022

  6. Mar 17, 2022

    Agent entered

    Representative
    HGF GmbH, OBC Suisse AG, Aeschengraben 29, 4051 Basel

    Published in Swissreg on 17.03.2022

  7. Jan 19, 2022

    Granted

    Published in Swissreg on 19.01.2022

Parties

Holder

Academisch Ziekenhuis Leiden h.o.d.n. LUMC

Academisch Ziekenhuis Leiden (h.o.d.n. LUMC)

Albinusdreef 2, 2333 ZA Leiden, NL

Agent

HGF GmbH

HGF GmbH OBC Suisse AG

Aeschengraben 29, 4051 Basel

Inventor

OVAA, Huib

2333 ZA Leiden, NL

VAN BOECKEL, Stan

2333 ZA Leiden, NL

MONS, Maria Wilhelmina Elisabeth

2333 ZA Leiden, NL

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.